Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease

This publication has 39 references indexed in Scilit:

• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
  Published by Elsevier ,2002
• Spastic paraplegia with iron deposits in the basal ganglia: A new X‐linked mental retardation syndrome
  American Journal of Medical Genetics, 1992
• Glutathione peroxidase in early and advanced Parkinson's disease.
  Journal of Neurology, Neurosurgery & Psychiatry, 1991
• Mitochondrial function and parental sex effect in Huntington's disease
  The Lancet, 1990
• Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence
  Biochemical and Biophysical Research Communications, 1990
• Mitochondrial Complex I Deficiency in Parkinson's Disease
  Journal of Neurochemistry, 1990
• Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
  Biochemical and Biophysical Research Communications, 1989
• Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
• Increased efflux rather than oxidation is the mechanism of glutathione depletion by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Biochemical and Biophysical Research Communications, 1987
• Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients
  Neuroscience Letters, 1986